[S-8 POS] Unity Biotechnology, Inc. SEC Filing
Unity Biotechnology filed Post-Effective Amendment No. 1 to terminate the effectiveness of multiple Form S-8 registration statements and to remove from registration all shares of its common stock that remained unsold under those registration statements. The amendment lists each affected S-8 (registration numbers and original share allocations by plan) and states the registration statements are amended to reflect deregistration of the unsold securities.
Unity Biotechnology ha presentato l'Emendamento Post-Effective n. 1 per terminare l'efficacia di più dichiarazioni di registrazione sul modulo S-8 e per rimuovere dalla registrazione tutte le azioni ordinarie che non erano state vendute a fronte di tali dichiarazioni. L'emendamento elenca ciascun S-8 interessato (numeri di registrazione e allocazioni iniziali di azioni per piano) e dichiara che le dichiarazioni di registrazione sono modificate per riflettere la deregistrazione dei titoli invenduti.
Unity Biotechnology presentó la Enmienda Post-Effective n.º 1 para terminar la vigencia de varias declaraciones de registro en el formulario S-8 y para eliminar de la registración todas las acciones ordinarias que permanecían sin vender bajo esas declaraciones. La enmienda lista cada S-8 afectado (números de registro y asignaciones iniciales de acciones por plan) y establece que las declaraciones de registro se modifican para reflejar la desregulación de los valores no vendidos.
Unity Biotechnology는 다수의 Form S-8 등록 명세서의 효력을 종료하고 해당 등록 명세서 하에 남아 팔리지 않은 보통주 전부를 등록에서 말소하기 위해 Post-Effective Amendment No. 1을 제출했습니다. 해당 수정안은 영향을 받는 각 S-8(등록번호 및 플랜별 최초 주식 배분)을 열거하고, 등록 명세서가 팔리지 않은 증권의 등록 말소를 반영하도록 수정되었음을 명시합니다.
Unity Biotechnology a déposé l'Amendement Post-Effective n°1 afin de mettre fin à la validité de plusieurs déclarations d'enregistrement sur le formulaire S-8 et de retirer de l'enregistrement toutes les actions ordinaires qui étaient restées invendues au titre de ces déclarations. L'amendement énumère chaque S-8 concerné (numéros d'enregistrement et allocations initiales d'actions par plan) et indique que les déclarations d'enregistrement sont modifiées pour refléter la radiation des titres invendus.
Unity Biotechnology hat die Post-Effective Amendment Nr. 1 eingereicht, um die Wirksamkeit mehrerer Form S-8-Registrierungserklärungen zu beenden und alle Aktien des Stammkapitals, die unter diesen Erklärungen unveräußert geblieben sind, aus der Registrierung zu streichen. Die Änderungsanmeldung listet jede betroffene S-8 auf (Registrierungsnummern und ursprüngliche Aktienzuweisungen je Plan) und gibt an, dass die Registrierungserklärungen geändert werden, um die Deregistrierung der unveräußerten Wertpapiere widerzuspiegeln.
- Post-Effective Amendment filed to terminate effectiveness of multiple S-8 registration statements, clarifying the company’s registration status.
- All unsold securities removed from registration under the listed S-8s, simplifying the company’s outstanding registration obligations.
- None.
Insights
TL;DR: Routine regulatory housekeeping: the company deregistered unsold shares under prior employee plans by amending multiple S-8 filings.
This filing is a procedural Post-Effective Amendment removing unsold shares from several Form S-8 registration statements. Such actions are commonly taken when companies no longer need the previously registered shares or when plans have been wound down or administratively adjusted. The filing itself contains no financial results, no disclosures about plan changes, and no forward-looking statements. It does not state any new grants, cancellations, or repurchases; it simply terminates the registration status of the unsold shares listed in each referenced S-8.
TL;DR: Administrative deregistration of unsold employee-plan shares; no direct financial impact disclosed in the filing.
The document lists multiple S-8 registration numbers with the originally registered share amounts by plan and confirms a Post-Effective Amendment has been filed to remove from registration any unsold securities. The filing notes that listed numbers do not reflect interim corporate actions such as stock splits. Because the filing contains no operational or balance-sheet data, it should be treated as a non-material administrative disclosure for investment analysis.
Unity Biotechnology ha presentato l'Emendamento Post-Effective n. 1 per terminare l'efficacia di più dichiarazioni di registrazione sul modulo S-8 e per rimuovere dalla registrazione tutte le azioni ordinarie che non erano state vendute a fronte di tali dichiarazioni. L'emendamento elenca ciascun S-8 interessato (numeri di registrazione e allocazioni iniziali di azioni per piano) e dichiara che le dichiarazioni di registrazione sono modificate per riflettere la deregistrazione dei titoli invenduti.
Unity Biotechnology presentó la Enmienda Post-Effective n.º 1 para terminar la vigencia de varias declaraciones de registro en el formulario S-8 y para eliminar de la registración todas las acciones ordinarias que permanecían sin vender bajo esas declaraciones. La enmienda lista cada S-8 afectado (números de registro y asignaciones iniciales de acciones por plan) y establece que las declaraciones de registro se modifican para reflejar la desregulación de los valores no vendidos.
Unity Biotechnology는 다수의 Form S-8 등록 명세서의 효력을 종료하고 해당 등록 명세서 하에 남아 팔리지 않은 보통주 전부를 등록에서 말소하기 위해 Post-Effective Amendment No. 1을 제출했습니다. 해당 수정안은 영향을 받는 각 S-8(등록번호 및 플랜별 최초 주식 배분)을 열거하고, 등록 명세서가 팔리지 않은 증권의 등록 말소를 반영하도록 수정되었음을 명시합니다.
Unity Biotechnology a déposé l'Amendement Post-Effective n°1 afin de mettre fin à la validité de plusieurs déclarations d'enregistrement sur le formulaire S-8 et de retirer de l'enregistrement toutes les actions ordinaires qui étaient restées invendues au titre de ces déclarations. L'amendement énumère chaque S-8 concerné (numéros d'enregistrement et allocations initiales d'actions par plan) et indique que les déclarations d'enregistrement sont modifiées pour refléter la radiation des titres invendus.
Unity Biotechnology hat die Post-Effective Amendment Nr. 1 eingereicht, um die Wirksamkeit mehrerer Form S-8-Registrierungserklärungen zu beenden und alle Aktien des Stammkapitals, die unter diesen Erklärungen unveräußert geblieben sind, aus der Registrierung zu streichen. Die Änderungsanmeldung listet jede betroffene S-8 auf (Registrierungsnummern und ursprüngliche Aktienzuweisungen je Plan) und gibt an, dass die Registrierungserklärungen geändert werden, um die Deregistrierung der unveräußerten Wertpapiere widerzuspiegeln.
FAQ
What did Unity Biotechnology (UBX) file in this S-8 Post-Effective Amendment?
Which registration statements were affected by Unity’s amendment?
Does the filing specify how many shares were deregistered?
Does this filing disclose any new equity grants or financial results?
Will the deregistration affect employee stock plans according to the filing?
